Factor viia inhibitory (thio)urea derivatives, their preparation and their use

Details for Australian Patent Application No. 2001277494 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Klingler, Otmar; Nestler, Hans-Peter; Schreuder, Herman; Matter, Hans; Schudok, Manfred

Agent Watermark

Pub. Number AU-B-2001277494

PCT Pub. Number WO01/94301

Priority 00112116 06.06.00 EP

Filing date 26 May 2001

Wipo publication date 17 December 2001

Acceptance publication date 4 May 2006

International Classifications

C07C 275/42 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/40 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 319/18 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

4 May 2006 Application Accepted

  Published as AU-B-2001277494

31 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001277496

2001277493